Catalyst Wire Dossier Catalyst Wire Dossier

MAXCLARITY II

· Stiefel, a GSK Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MAXCLARITY II, covering 2017-03-15 to 2018-01-08. Get the full timeline:

Most recent: Clinical Trial Update: U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne [Phase 4]

See pricing